Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Viborg Dyrehospital ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.7% 2.0% 1.8% 1.2% 1.2% 1.9% 12.0% 12.0%   Credit score (0-100)   53 69 71 80 81 68 20 20   Credit rating   BBB A A A A A BB BB   Credit limit (kDKK)   0.0 0.3 1.7 68.0 74.3 0.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,219 4,090 4,089 5,078 5,755 5,923 0.0 0.0   EBITDA   299 1,564 1,564 1,125 1,134 379 0.0 0.0   EBIT   245 1,453 1,452 953 921 148 0.0 0.0   Pre-tax profit (PTP)   220.6 1,478.0 1,478.3 992.0 955.0 153.0 0.0 0.0   Net earnings   171.3 1,152.0 1,152.3 775.0 748.0 118.8 0.0 0.0   Pre-tax profit without non-rec. items   221 1,478 1,478 992 955 153 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   291 758 757 937 1,208 1,368 0.0 0.0   Shareholders equity total   311 1,819 1,820 2,095 2,143 1,561 1,411 1,411   Interest-bearing liabilities   329 33.0 32.8 33.0 423 1,098 0.0 0.0   Balance sheet total (assets)   1,128 4,260 4,260 3,698 4,399 4,285 1,411 1,411   Net Debt   220 -840 -841 -68.0 180 1,048 -1,411 -1,411     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,219 4,090 4,089 5,078 5,755 5,923 0.0 0.0   Gross profit growth   255.4% 235.6% -0.0% 24.2% 13.3% 2.9% -100.0% 0.0%   Employees   0 6 6 10 11 12 0 0   Employee growth %   -100.0% 0.0% 0.0% 66.7% 10.0% 9.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,128 4,260 4,260 3,698 4,399 4,285 1,411 1,411   Balance sheet change%   56.5% 277.5% -0.0% -13.2% 19.0% -2.6% -67.1% 0.0%   Added value   298.9 1,564.0 1,563.9 1,125.0 1,093.0 379.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   134 356 -112 8 58 -71 -1,368 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   20.1% 35.5% 35.5% 18.8% 16.0% 2.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   28.4% 55.1% 34.8% 25.1% 23.8% 4.3% 0.0% 0.0%   ROI %   44.5% 117.0% 78.7% 49.3% 40.4% 7.0% 0.0% 0.0%   ROE %   76.2% 108.2% 63.3% 39.6% 35.3% 6.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   27.5% 42.7% 42.7% 56.7% 48.7% 36.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   73.6% -53.7% -53.8% -6.0% 15.9% 276.5% 0.0% 0.0%   Gearing %   105.8% 1.8% 1.8% 1.6% 19.7% 70.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.8% 3.3% 14.1% 18.3% 3.5% 4.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 1.4 1.4 1.5 1.2 0.9 0.0 0.0   Current Ratio   1.0 1.4 1.4 1.7 1.4 1.0 0.0 0.0   Cash and cash equivalent   108.7 873.0 873.7 101.0 243.0 50.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   8.5 1,031.0 1,031.7 1,088.0 868.0 119.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 261 261 113 99 32 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 261 261 113 103 32 0 0   EBIT / employee   0 242 242 95 84 12 0 0   Net earnings / employee   0 192 192 78 68 10 0 0